These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 263181)

  • 21. Effects of adenosine A1 and A2 receptor activation on electrically evoked dopamine and acetylcholine release from rat striatal slices.
    Jin S; Johansson B; Fredholm BB
    J Pharmacol Exp Ther; 1993 Nov; 267(2):801-8. PubMed ID: 7902434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased sensitivity of striatal dopamine release to H2O2 upon chronic rotenone treatment.
    Milusheva E; Baranyi M; Kittel A; Sperlágh B; Vizi ES
    Free Radic Biol Med; 2005 Jul; 39(1):133-42. PubMed ID: 15925285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of NMDA and GABAA receptors in the inhibiting effect of 3 MPa nitrogen on striatal dopamine level.
    Lavoute C; Weiss M; Rostain JC
    Brain Res; 2007 Oct; 1176():37-44. PubMed ID: 17900538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of intrastriatal glutamic acid injection on rat cerebellar cyclic GMP levels.
    Lautié JP; Kouyoumdjian JC; Haidamous M; Lacombe C; Grignon L; Gonnard P
    J Neurochem; 1981 Sep; 37(3):801-3. PubMed ID: 6115892
    [No Abstract]   [Full Text] [Related]  

  • 25. Stimulatory effect of L-glutamate and related amino acids on [3H]dopamine release from rat striatum: an in vitro model for glutamate actions.
    Roberts PJ; Anderson SD
    J Neurochem; 1979 May; 32(5):1539-45. PubMed ID: 438822
    [No Abstract]   [Full Text] [Related]  

  • 26. [The sodium oxybutyrate and nooglutil correction of dopamine release in the striatum of prenatally alcoholized rat pups].
    Kovalev GI; Budygin EA; Gaĭnetdinov RR; Kudrin VS; Trofimov SS; Ostrovskaia RU
    Biull Eksp Biol Med; 1993 Jul; 116(7):56-8. PubMed ID: 8400184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Responses of an identified dopamine-containing neurone to iontophoretically applied drugs.
    Logan SD; Cottrell GA
    Neuropharmacology; 1975; 14(5-6):453-5. PubMed ID: 1153090
    [No Abstract]   [Full Text] [Related]  

  • 28. [Comparative pharmacology].
    Kerkut GA
    Zh Evol Biokhim Fiziol; 1977; 13(3):325-9. PubMed ID: 197747
    [No Abstract]   [Full Text] [Related]  

  • 29. Substance P in the substantia nigra.
    Davies J; Dray A
    Brain Res; 1976 May; 107(3):623-7. PubMed ID: 1268746
    [No Abstract]   [Full Text] [Related]  

  • 30. Changes in amino acid sensitivity during polypeptide "desensitisation".
    Davies J; Dray A
    Nature; 1976 Aug; 262(5569):606-7. PubMed ID: 958426
    [No Abstract]   [Full Text] [Related]  

  • 31. [Psychological effective value of crystalline L(+)-glutamic acid, gamma-aminobutyric acid and complex proteins].
    MULLER R
    Arzneimittelforschung; 1955 Sep; 5(9):547-51. PubMed ID: 13276279
    [No Abstract]   [Full Text] [Related]  

  • 32. [Increased acetylcholine formation in the brain after extended glutamic acid diet].
    KLOTZSCHE C
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1956; 227(5):409-13. PubMed ID: 13334545
    [No Abstract]   [Full Text] [Related]  

  • 33. A commentary on comparative phamacology.
    Kerkut GA
    Comp Biochem Physiol C Comp Pharmacol; 1976; 55(1):1-3. PubMed ID: 8265
    [No Abstract]   [Full Text] [Related]  

  • 34. [The effect of glutamic acid on cholinergic excitation in the central and peripheral synapses].
    DIABLOVA PE
    Biull Eksp Biol Med; 1960 Jan; 49():83-6. PubMed ID: 13816504
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effects of glutamic acid on excitability and learning capacity in rats].
    HELM-ZELLER HM
    Z Psychol Z Angew Psychol; 1956 Apr; 159(1-2):58-84. PubMed ID: 13353418
    [No Abstract]   [Full Text] [Related]  

  • 36. [Glutamic acid and infection].
    DURAND P; RENOUX G; HUET M
    C R Hebd Seances Acad Sci; 1953 Apr; 236(17):1705-7. PubMed ID: 13067274
    [No Abstract]   [Full Text] [Related]  

  • 37. Intrastriatal regulation of DA release from dopaminergic terminals.
    Giorguieff MF; Kemel ML; Blesson MJ; Glowinski J
    Int J Neurol; 1979; 13(1-4):127-34. PubMed ID: 263181
    [No Abstract]   [Full Text] [Related]  

  • 38. Role of various amino acids on the modulation of dopamine release from nigro-striatal dopaminergic neurones.
    Giorguieff-Chesselet MF; Besson MJ; Cheramy A; Glowinski J
    J Physiol (Paris); 1979; 75(6):611-3. PubMed ID: 547062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The susceptibility to acetylcholine and dopamine in the caudate nucleus of cats with chronic nigrostriatal lesions.
    Sphelmann R
    Trans Am Neurol Assoc; 1974; 99():255-7. PubMed ID: 4156892
    [No Abstract]   [Full Text] [Related]  

  • 40. Transmitter release by non-receptor activation of the alpha-subunit of guanine nucleotide regulatory protein in rat striatal slices.
    Zelles T; Chernaeva L; Baranyi M; Déri Z; Adam-Vizi V; Vizi ES
    J Neurosci Res; 1995 Oct; 42(2):242-51. PubMed ID: 8568925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.